ADVANCED SEARCH
HOME
ABOUT US
AGENCIES
NEWS RELEASES
MULTIMEDIA
SPECIAL EVENTS
TOOLS
CONTACT
News Releases
Health & Medical
Translations:
All (English)
Chinese - Simplified
Chinese - Traditional
Hindi
Indonesian
Japanese
Korean
Malay
Pashto
Thai
Urdu
Vietnamese
Arabic
Bulgarian
Burmese
Canadian French
Czech
Danish
Dutch
Estonian
Finnish
French
German
Greek
Hebrew
Hungarian
Italian
Latvian
Lithuanian
Norwegian
Polish
Portuguese (European)
Portuguese (Latin American)
Russian
Slovakian
Spanish (European)
Spanish (Latin American)
Swedish
Turkish
Health & Medical Results: 1980 item(s)
University Health Network (UHN) Selects Kailo Medical's SonoRe...
- 28 September 2021 01:12
CALGARY, AB, Sept. 28, 2021 /PRNewswire-AsiaNet/ -- - Quality Improvement via Automated Structured Reporting Kailo Medical, a leader in medical imaging workflow solutions, today announced that the University Health Network (UHN), a group of Ontario hospitals including Toronto General,...
GenScript ProBio Congratulates EyeGene for Clinical Trial Appr...
- 27 September 2021 21:14
NANJING, China, Sept. 27, 2021 /PRNewswire-AsiaNet/ -- EyeGene's mRNA vaccine against COVID-19, namely "EG-COVID", has recently been approved for clinical trials by South Korea's Ministry of Food and Drug Safety (MFDS). GenScript ProBio hereby extended its warm congratulations to the partner. EG-CO...
LEAD Horizon: How travelers in Austria gargle against the coro...
- 27 September 2021 09:00
JOHANNESBURG, Sept. 27, 2021/PRNewswire-AsiaNet/-- Austrian success model with gold standard tests is possible worldwide Vienna got through the pandemic better in comparison to other European cities - thanks to a specially developed PCR test by the Austrian company LEAD Horizon, which is alrea...
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinica...
- 24 September 2021 11:17
GAITHERSBURG, Md., Sept. 24, 2021 /PRNewswire-AsiaNet/ -- - Pivotal Phase 3 trial achieved all primary endpoints, demonstrating non-inferiority to a leading U.S.-licensed quadrivalent influenza vaccine - NanoFlu(TM) vaccine candidate induced significantly enhanced cell-mediated immune responses - N...
Novavax and Serum Institute of India Announce Submission to Wo...
- 24 September 2021 01:04
GAITHERSBURG, Md., Sept. 24, 2021 /PRNewswire-AsiaNet/ -- -- Novavax and Serum Institute of India file regulatory submission for World Health Organization Emergency Use Listing of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine Novavax, Inc. (Nasdaq: NVAX), a bio...
Hainan Boao Lecheng International Medical Tourism Pilot Zone h...
- 23 September 2021 22:16
BOAO, China, Sept. 23, 2021 /PRNewswire-Asianet/ -- - The event is co-organized by Winhealth Pharma The Hainan Boao Lecheng International Medical Tourism Pilot Zone ("Lecheng Pilot Zone")'s virtual promotional event to explain the favorable investment policies put in place for Japanese businesse...
"Human Brains: Conversations", an online project dedicated to ...
- 23 September 2021 20:00
MILAN, Sept. 23, 2021 /PRNewswire-AsiaNet/ -- Fondazione Prada presents the online project "Human Brains: Conversations," the second phase of the multidisciplinary program "Human Brains" dedicated to brain studies. "Conversations" will take place from September 2021 to April 2022 and will be ...
MedAlliance announces completion of enrollment in Japanese SEL...
- 23 September 2021 08:00
GENEVA, Sept. 23, 2021 /PRNewswire-AsiaNet/ -- MedAlliance, with its Japanese partner MDK Medical, has completed enrollment in the clinical study of its novel Sirolimus Drug Eluting Balloon (DEB), SELUTION SLR(TM), for the treatment of peripheral arterial disease (PAD). This follows the ac...
INOVIO Receives Regulatory Authorization to Conduct Phase 3 Ef...
- 22 September 2021 22:00
PLYMOUTH MEETING, Pa., Sept. 22, 2021 /PRNewswire-AsiaNet/ -- -- News follows recent regulatory authorizations to proceed with the trial in Brazil and the Philippines -- INOVIO and partner Advaccine are collaborating on the global Phase 3 trial in regions underserved by COVID-19 vaccines...
pHOXBIO Announces Breakthrough Clinical Trial Results Concludi...
- 22 September 2021 17:00
LONDON and NEW YORK, Sept. 22, 2021 /PRNewswire-AsiaNet/-- - pHOXWELL significantly reduced SARS-CoV-2 infection by 63% with tolerability comparable to placebo in high-risk population of healthcare workers - Novel self-administered nasal spray designed to augment existing preventive measures for SARS-CoV...
Page 65 of 198
...
60
61
62
63
64
65
66
67
68
69
...
Go to page
All Categories
Automotive, Transport & Logistics
Business & Finance
Education
Energy, Mining & Resources
Environment
Events
General News
Health & Medical
Manufacturing
Media, Entertainment & Fashion
Property & Development
Retail & Hospitality
Science
Social Welfare
Sport
Technology & Innovation
Tourism & Leisure
Advanced Search
Search for either:
News Releases
Translations:
All (English)
Chinese - Simplified
Chinese - Traditional
Hindi
Indonesian
Japanese
Korean
Malay
Pashto
Thai
Urdu
Vietnamese
Arabic
Bulgarian
Burmese
Canadian French
Czech
Danish
Dutch
Estonian
Finnish
French
German
Greek
Hebrew
Hungarian
Italian
Latvian
Lithuanian
Norwegian
Polish
Portuguese (European)
Portuguese (Latin American)
Russian
Slovakian
Spanish (European)
Spanish (Latin American)
Swedish
Turkish
or
Multimedia
Type:
all
images
audio
video
mnr
other
Category:
All Categories
Automotive, Transport & Logistics
Business & Finance
Education
Energy, Mining & Resources
Environment
Events
General News
Health & Medical
Manufacturing
Media, Entertainment & Fashion
Property & Development
Retail & Hospitality
Science
Social Welfare
Sport
Technology & Innovation
Tourism & Leisure
Keywords:
Date range:
All
Range
From:
Open the calendar popup.
<<
<
September 2024
>
>>
M
T
W
T
F
S
S
35
26
27
28
29
30
31
1
36
2
3
4
5
6
7
8
37
9
10
11
12
13
14
15
38
16
17
18
19
20
21
22
39
23
24
25
26
27
28
29
40
30
1
2
3
4
5
6
To:
Open the calendar popup.
<<
<
September 2024
>
>>
M
T
W
T
F
S
S
35
26
27
28
29
30
31
1
36
2
3
4
5
6
7
8
37
9
10
11
12
13
14
15
38
16
17
18
19
20
21
22
39
23
24
25
26
27
28
29
40
30
1
2
3
4
5
6
Entries per page: